Zio AT ECG Monitoring System vs iPredict Eye Screening
AI Verdict
Choose Zio AT ECG Monitoring System if…
Choose the Zio AT ECG Monitoring System if your patient requires continuous, long-term cardiac monitoring for up to 14 days to detect elusive or intermittent arrhythmias. This system is ideal for identifying both symptomatic and asymptomatic cardiac events with AI-powered analysis, providing comprehensive reports for a definitive diagnosis.
View Zio AT ECG Monitoring System →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if you need a rapid, non-invasive AI-powered solution for screening multiple ocular conditions like AMD, Diabetic Retinopathy, and Glaucoma, particularly in primary care or telemedicine settings. This tool also offers valuable risk prediction for systemic diseases such as stroke and heart attack, integrating seamlessly with existing EHRs.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio AT ECG Monitoring System | iPredict Eye Screening |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (data analytics and clinician portal) | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iPredict Eye ScreeningiPredict emphasizes ease of operation, a non-invasive approach, and rapid results (test in <5 min, report in <60 sec) via an advanced touchscreen, suggesting a highly streamlined user experience for the screening process. Zio AT involves a wearable patch for continuous monitoring, which is a different kind of user interaction focused on long-term data collection rather than immediate operational ease.
Clinical Value
iPredict Eye ScreeningiPredict offers multi-disease screening for Diabetic Retinopathy, AMD, and Glaucoma, alongside risk prediction for systemic diseases like stroke and heart attack, all from a single, rapid eye scan. This broad diagnostic and predictive capability from one non-invasive test provides extensive clinical utility across multiple specialties. Zio AT provides deep, continuous monitoring for cardiac arrhythmias, which is also highly valuable but more focused on a single physiological system.
Pricing & Value
iPredict Eye ScreeningiPredict offers greater transparency regarding its pricing model, providing an estimated per-patient screening cost ($10-$20) and specifying a Software as a Service (SaaS) model. In contrast, Zio AT's pricing is not publicly disclosed beyond stating it involves service fees, making it harder to assess its value proposition upfront.
Enterprise Readiness
Zio AT ECG Monitoring SystemZio AT explicitly states it has a Business Associate Agreement (BAA), which is a crucial component for healthcare enterprises to ensure HIPAA compliance when working with third-party vendors. While iPredict is HIPAA compliant and cloud-based, the lack of explicit mention of a BAA in the provided facts makes Tool A appear more comprehensively ready for enterprise deployment.
Innovation
iPredict Eye ScreeningiPredict demonstrates significant innovation by leveraging AI to screen for multiple ocular diseases (DR, AMD, Glaucoma) and simultaneously predict the risk of systemic conditions like stroke and heart attack from retinal images. This ability to derive broad systemic health insights from a single, non-invasive eye scan represents a novel and impactful application of AI in healthcare. Zio AT's continuous wearable ECG monitoring is also innovative but more focused on a single physiological system.
Support & Docs
TieBoth companies appear to offer standard support and documentation for their respective products, including resources for healthcare professionals and patients, as well as technical assistance. Without more specific details or comparative reviews on the quality or breadth of these services, it is not possible to definitively distinguish between the two.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio AT ECG Monitoring System | iPredict Eye Screening |
|---|---|---|
| Name | Zio AT ECG Monitoring System | iPredict Eye Screening |
| Primary Medical Focus | Continuous, AI-powered ECG monitoring for long-term arrhythmia detection. | AI-powered screening for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma. |
| Targeted Specialties | Cardiology | Family Medicine, Internal Medicine, Ophthalmology |
| Key AI Application | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection. | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; AI-Based Telemedicine Service. |
| Patient Interface/Device | Wearable Zio AT patch for continuous ECG recording, wireless gateway, MyZiou00ae patient mobile app. | Non-invasive, with an advanced touchscreen interface for image analysis. |
| Additional Screening/Prediction | Not specified | Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients; Electronic Health Record (EHR) Solutions. |
Videos
Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and iPredict Eye Screening.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio AT ECG Monitoring System or iPredict Eye Screening
Backers
Who funded each tool's parent company.